TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cocinar Para su Salud! (Cook for Your Life!): Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Brief Summary: The primary objectives of this study are to determine the effect of the dietary intervention (Cocinar para su salud! Program) vs. control (standard written nutrition education materials for cancer survivors) in Hispanic breast cancer survivors with early stage breast cancer on 1) daily servings of fruit and vegetable intake from baseline to 6 months; and 2) percent energy from fat and fat-related dietary habits from baseline to 6 months.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Eat Smart, Live Better | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Eat Smart, Live Better; Assigned to Arm(s): Treatment
B: Arm Label: Intensive Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Intensive | Arm Label: Routine Portfolio; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Dietary Portfolio - Routine | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Control (low saturated fat therapeutic diet) | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Intensive; Assigned to Arm(s): Intensive Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Dietary Portfolio - Routine; Assigned to Arm(s): Routine Portfolio | Intervention Type: DIETARY_SUPPLEMENT; Name: Control (low saturated fat therapeutic diet); Assigned to Arm(s): Control
C: Arm Label: Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Other: mediterranean diet | Arm Label: normocaloric diet; Type: ACTIVE_COMPARATOR; Interventions: Other: normocaloric diet | Intervention Type: OTHER; Name: mediterranean diet; Assigned to Arm(s): Mediterranean Diet | Intervention Type: OTHER; Name: normocaloric diet; Assigned to Arm(s): normocaloric diet
D: Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written dietary recommendations | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Behavioral: Cocinar Para Su Salud Program | Intervention Type: BEHAVIORAL; Name: Cocinar Para Su Salud Program; Assigned to Arm(s): Arm B | Intervention Type: BEHAVIORAL; Name: Written dietary recommendations; Assigned to Arm(s): Arm A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Managing the Dysexecutive Syndrome Following Traumatic Brain Injury: An Ecologically Valid Rehabilitation Approach
Brief Summary: Successful community participation following acquired brain injury (ABI) continues to be an elusive goal for patients, clinicians and researchers. Our pilot work shows that community dwelling survivors of ABI can significantly improve performance on self-identified real- world performance problems and that they can transfer this learning to improve goals not trained in the treatment sessions. We will compare two types of rehabilitation intervention using a randomized controlled trial. We will also interview survivors, their significant others and clinicians regarding their experiences with each intervention to help us discover what works best.


Options:
A: Arm Label: care guide; Type: EXPERIMENTAL; Interventions: Behavioral: education and care guide | Arm Label: no care guide; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: education only | Intervention Type: BEHAVIORAL; Name: education and care guide; Assigned to Arm(s): care guide | Intervention Type: BEHAVIORAL; Name: education only; Assigned to Arm(s): no care guide
B: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
C: Arm Label: Feedback group; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback of daily walking activity | Arm Label: No-feedback group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Feedback of daily walking activity; Assigned to Arm(s): Feedback group
D: Arm Label: Conventional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation. | Arm Label: Novel rehabilitation approach; Type: EXPERIMENTAL; Interventions: Behavioral: Novel rehabilitation approach | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation.; Assigned to Arm(s): Conventional rehabilitation | Intervention Type: BEHAVIORAL; Name: Novel rehabilitation approach; Assigned to Arm(s): Novel rehabilitation approach

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Managing the Dysexecutive Syndrome Following Traumatic Brain Injury: An Ecologically Valid Rehabilitation Approach
Brief Summary: Successful community participation following acquired brain injury (ABI) continues to be an elusive goal for patients, clinicians and researchers. Our pilot work shows that community dwelling survivors of ABI can significantly improve performance on self-identified real- world performance problems and that they can transfer this learning to improve goals not trained in the treatment sessions. We will compare two types of rehabilitation intervention using a randomized controlled trial. We will also interview survivors, their significant others and clinicians regarding their experiences with each intervention to help us discover what works best.


Options:
A: Arm Label: animal assisted therapy; Type: EXPERIMENTAL; Interventions: Other: animal assisted therapy | Arm Label: standard therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: standard therapy | Intervention Type: OTHER; Name: animal assisted therapy; Assigned to Arm(s): animal assisted therapy | Intervention Type: OTHER; Name: standard therapy; Assigned to Arm(s): standard therapy
B: Arm Label: sequential training group (SEQ); Type: EXPERIMENTAL; Interventions: Behavioral: aerobic exercise training, Behavioral: cognitive training | Arm Label: control intervention group (CI); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: control training | Intervention Type: BEHAVIORAL; Name: aerobic exercise training; Assigned to Arm(s): sequential training group (SEQ) | Intervention Type: BEHAVIORAL; Name: control training; Assigned to Arm(s): control intervention group (CI) | Intervention Type: BEHAVIORAL; Name: cognitive training; Assigned to Arm(s): sequential training group (SEQ)
C: Arm Label: Conventional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation. | Arm Label: Novel rehabilitation approach; Type: EXPERIMENTAL; Interventions: Behavioral: Novel rehabilitation approach | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation.; Assigned to Arm(s): Conventional rehabilitation | Intervention Type: BEHAVIORAL; Name: Novel rehabilitation approach; Assigned to Arm(s): Novel rehabilitation approach
D: Arm Label: Rehabilitation training; Type: EXPERIMENTAL; Interventions: Other: Rehabilitation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Rehabilitation; Assigned to Arm(s): Rehabilitation training

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Dose Dexamethasone as Pain Treatment After Arthroscopic Shoulder Surgery: A Randomised, Blinded Clinical Trial
Brief Summary: The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.


Options:
A: Arm Label: Methylprednisolone; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone 125mg | Arm Label: placebo/sodium chloride; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 2 ml | Intervention Type: DRUG; Name: Methylprednisolone 125mg; Assigned to Arm(s): Methylprednisolone | Intervention Type: DRUG; Name: Sodium Chloride 2 ml; Assigned to Arm(s): placebo/sodium chloride
B: Arm Label: 8 mg dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Placebo, saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: 40 mg dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 40 mg dexamethasone, 8 mg dexamethasone, Placebo, saline
C: Intervention Type: DRUG; Name: MK0869, aprepitant; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron IV; Assigned to Arm(s): N/A
D: Arm Label: PLACEBO Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: PLACEBO | Arm Label: DEXAMETHASONE Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: ONDANSETRON; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ondansetron | Arm Label: DEXAMETHASONE + ONDANSETRON; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone + Ondansetron | Intervention Type: DRUG; Name: PLACEBO; Assigned to Arm(s): PLACEBO Group | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): DEXAMETHASONE Group | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): ONDANSETRON | Intervention Type: DRUG; Name: Dexamethasone + Ondansetron; Assigned to Arm(s): DEXAMETHASONE + ONDANSETRON

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: High Dose Dexamethasone as Pain Treatment After Arthroscopic Shoulder Surgery: A Randomised, Blinded Clinical Trial
Brief Summary: The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.


Options:
A: Arm Label: Dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, Drug: Morphine, Drug: Zofran, Drug: Paracetamol, Drug: Ibuprofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo, Drug: Morphine, Drug: Zofran, Drug: Paracetamol, Drug: Ibuprofen | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Zofran; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Dexamethasone, Placebo | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Dexamethasone, Placebo
B: Arm Label: 8 mg dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Placebo, saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: 40 mg dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 40 mg dexamethasone, 8 mg dexamethasone, Placebo, saline
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isotonic NaCl | Arm Label: dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: dexamethasone phosphate | Intervention Type: DRUG; Name: dexamethasone phosphate; Assigned to Arm(s): dexamethasone | Intervention Type: DRUG; Name: Isotonic NaCl; Assigned to Arm(s): Placebo
D: Arm Label: A, 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A, 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethason Helvepharm ® | Intervention Type: DRUG; Name: Dexamethason Helvepharm ®; Assigned to Arm(s): A, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A, 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventions for Chronic Diseases: Effect of Patient Values and Effectiveness Information on Patients' Choice of Therapy, Adherence to Therapy and Satisfaction With Therapy
Brief Summary: Few studies have explored how specific formats of effectiveness information effect on real patients' decisions. We only know little about what kind of format would be the optimal to help patients make well-informed real-life decisions corresponding to their preferences.

The trial is developed in a clinical randomised design to study risk communication in the shared decision making between general practitioners (GP) and their patients in primary prevention with of cholesterol lowering drug. Endpoints are effect of GPs' information about treatment effectiveness and their patients' values on patients' tendency to accept and adhere to the treatment as well as their feeling of content with the choice made. GPs are randomised to inform about risk and treatment effectiveness by means of either absolute risk reduction (ARR) or Prolongation of Life (POL). Afterwards patients are invited to answer questionnaires concerning their content with decisions and reflections. Patients' redemption of prescriptions during the following week and the first year are recorded through an electronic database.

57 GPs and 248 patients have been enrolled in the trial.


Options:
A: Arm Label: Rating and Ranking Group; Type: OTHER; Interventions: Other: Rating and Ranking Task | Arm Label: Discrete Choice Group; Type: OTHER; Interventions: Other: Discrete Choice Task | Arm Label: Balance Sheet Group; Type: OTHER; Interventions: Other: Balance Sheet Task | Intervention Type: OTHER; Name: Rating and Ranking Task; Assigned to Arm(s): Rating and Ranking Group | Intervention Type: OTHER; Name: Discrete Choice Task; Assigned to Arm(s): Discrete Choice Group | Intervention Type: OTHER; Name: Balance Sheet Task; Assigned to Arm(s): Balance Sheet Group
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Patient video decision aid & telephone coaching | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Printed educational brochure | Intervention Type: BEHAVIORAL; Name: Patient video decision aid & telephone coaching; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Printed educational brochure; Assigned to Arm(s): 2
C: Arm Label: Decision Aid; Type: EXPERIMENTAL; Interventions: Other: Decision Aid | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision Aid
D: Arm Label: Absolute risk reduction information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Absolute risk reduction | Arm Label: Prolongation of life information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prolongation of life | Intervention Type: BEHAVIORAL; Name: Absolute risk reduction; Assigned to Arm(s): Absolute risk reduction information | Intervention Type: BEHAVIORAL; Name: Prolongation of life; Assigned to Arm(s): Prolongation of life information

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interventions for Chronic Diseases: Effect of Patient Values and Effectiveness Information on Patients' Choice of Therapy, Adherence to Therapy and Satisfaction With Therapy
Brief Summary: Few studies have explored how specific formats of effectiveness information effect on real patients' decisions. We only know little about what kind of format would be the optimal to help patients make well-informed real-life decisions corresponding to their preferences.

The trial is developed in a clinical randomised design to study risk communication in the shared decision making between general practitioners (GP) and their patients in primary prevention with of cholesterol lowering drug. Endpoints are effect of GPs' information about treatment effectiveness and their patients' values on patients' tendency to accept and adhere to the treatment as well as their feeling of content with the choice made. GPs are randomised to inform about risk and treatment effectiveness by means of either absolute risk reduction (ARR) or Prolongation of Life (POL). Afterwards patients are invited to answer questionnaires concerning their content with decisions and reflections. Patients' redemption of prescriptions during the following week and the first year are recorded through an electronic database.

57 GPs and 248 patients have been enrolled in the trial.


Options:
A: Arm Label: Counseling; Type: NO_INTERVENTION; Interventions: Other: counseling intervention, Other: CD-ROM intervention | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): Counseling | Intervention Type: OTHER; Name: CD-ROM intervention; Assigned to Arm(s): Counseling
B: Arm Label: Absolute risk reduction information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Absolute risk reduction | Arm Label: Prolongation of life information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prolongation of life | Intervention Type: BEHAVIORAL; Name: Absolute risk reduction; Assigned to Arm(s): Absolute risk reduction information | Intervention Type: BEHAVIORAL; Name: Prolongation of life; Assigned to Arm(s): Prolongation of life information
C: Arm Label: Traditional CERSG Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Community Health Worker Diabetes Education: Print media | Arm Label: Web-Based Materials Arm; Type: EXPERIMENTAL; Interventions: Behavioral: CHW Diabetes Education: tailored web site | Intervention Type: BEHAVIORAL; Name: Community Health Worker Diabetes Education: Print media; Assigned to Arm(s): Traditional CERSG Arm | Intervention Type: BEHAVIORAL; Name: CHW Diabetes Education: tailored web site; Assigned to Arm(s): Web-Based Materials Arm
D: Arm Label: Telephone Genetic Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Genetic Counseling | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Telephone Genetic Counseling; Assigned to Arm(s): Telephone Genetic Counseling | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intensive Management of Pressure and Volume Expansion in Patients With Subarachnoid Hemorrhage
Brief Summary: The purpose of our study is to determine how well Triple-H works and how safe it is. The investigators are hoping to determine the effects of starting the therapy early and to explore if hypervolemia and/or hypertension are beneficial, and what the optimal target ranges are.


Options:
A: Arm Label: Normal Fluids & Normal Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Increased Fluids & Normal Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Normal Fluids & Higher Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Arm Label: Increased Fluids & Higher Blood Pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Fluid manipulation, Other: Blood Pressure Manipulation | Intervention Type: OTHER; Name: Fluid manipulation; Assigned to Arm(s): Increased Fluids & Higher Blood Pressure, Increased Fluids & Normal Blood Pressure, Normal Fluids & Higher Blood Pressure, Normal Fluids & Normal Blood Pressure | Intervention Type: OTHER; Name: Blood Pressure Manipulation; Assigned to Arm(s): Increased Fluids & Higher Blood Pressure, Increased Fluids & Normal Blood Pressure, Normal Fluids & Higher Blood Pressure, Normal Fluids & Normal Blood Pressure
B: Arm Label: Intensive BP lowering; Type: OTHER; Interventions: Other: Blood pressure management policies | Arm Label: Guideline recommended BP lowering; Type: OTHER; Interventions: Other: Blood pressure management policies | Intervention Type: OTHER; Name: Blood pressure management policies; Assigned to Arm(s): Guideline recommended BP lowering, Intensive BP lowering
C: Arm Label: Standard SBP Reduction Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous nicardipine hydrochloride | Arm Label: Intensive SBP Reduction Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Intravenous nicardipine hydrochloride | Intervention Type: DRUG; Name: Intravenous nicardipine hydrochloride; Assigned to Arm(s): Intensive SBP Reduction Arm, Standard SBP Reduction Arm
D: Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Induced hypertension; Type: ACTIVE_COMPARATOR; Interventions: Other: Induced hypertension | Intervention Type: OTHER; Name: Induced hypertension; Assigned to Arm(s): Induced hypertension

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
Brief Summary: The purpose of this study is to evaluate the efficacy of an active rehabilitation program on disability and quality of life of patients affected by dermatomyositis and polymyositis.


Options:
A: Arm Label: active rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Other: Active rehabilitation | Arm Label: conventional care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Active rehabilitation; Assigned to Arm(s): active rehabilitation
B: Arm Label: Energetic; Type: EXPERIMENTAL; Interventions: Behavioral: Energetic | Arm Label: Control group; Type: OTHER; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: Energetic; Assigned to Arm(s): Energetic | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
C: Arm Label: Sjogren and Myositis Control (no control for takayasu's); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Sjogren, Myositis and Takayasu's Trained; Type: EXPERIMENTAL; Interventions: Other: Exercise training | Intervention Type: OTHER; Name: Exercise training; Assigned to Arm(s): Sjogren, Myositis and Takayasu's Trained
D: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Other: Physical Exercise | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physical Exercise; Assigned to Arm(s): Exercise

Answer: A